ArticleTherapeutic advances in neurological disorders2011
Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.
Article in Therapeutic advances in neurological disorders, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 91 citations in OpenAlex.
- Review of atypical optic neuritis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Review
- Article
- Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017.Scientific reports · 2024Article
- Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy.Journal of nanobiotechnology · 2023Review
- Risk Factors for Multiple Sclerosis Development After Optic Neuritis Diagnosis Using a Nationwide Health Records Database.Neuro-ophthalmology (Aeolus Press) · 2023Article
- Sub internal limiting membrane hemorrhage followed by bilateral optic disc hemorrhage in Kikuchi-Fujimoto disease: a case report.BMC ophthalmology · 2021Article
- The Effects of Two Nrf2 Activators, Bardoxolone Methyl and Omaveloxolone, on Retinal Ganglion Cell Survival during Ischemic Optic Neuropathy.Antioxidants (Basel, Switzerland) · 2021Article
- Relapsing neuromyelitis optica in an adolescent girl.BMJ case reports · 2021Article
- Shear wave elastography in optic neuritis: diagnostic accuracy of the optic nerve and adjacent fat tissue values.Journal of ultrasonography · 2021Article
- Comparison of the Structure and Function of the Retina and the Optic Nerve in Patients with a History of Multiple Sclerosis-Related Demyelinating Retrobulbar Optic Neuritis Treated and Not Treated with Systemic Steroid Therapy.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- Comparing Colored and White-Black Visual Evoked Potentials in Multiple Sclerosis Patients.Noro psikiyatri arsivi · 2020Article
- Vision loss in an immunocompetent child post varicella infection: A case report.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2020Article
- Atypical optic neuritis - a case with a new surprise every visit.GMS ophthalmology cases · 2020Article
- Low Contrast Visual Acuity Might Help to Detect Previous Optic Neuritis.Frontiers in neurology · 2020Article
- Neurosyphilis presenting as visually asymptomatic bilateral optic perineuritis.BMJ case reports · 2019Article
- Spectrally fat-suppressed coronal 2D TSE sequences may be more sensitive than 2D STIR for the detection of hyperintense optic nerve lesions.European radiology · 2019Article
- Yield of screening blood work and MRI of the brain and orbits in the work-up of unilateral chronic optic neuropathy.Eye (London, England) · 2019Article
- Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.Neurology · 2019Review
- Optic neuritis caused by the re-emerging great masquerader.BMJ case reports · 2018Article
- Association ofMedicina (Kaunas, Lithuania) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Demyelinating optic neuritis (ON) is the most common cause of optic neuropathy typically presenting with a subacute painful visual loss. In 20% of patients with multiple sclerosis (MS), ON is the presenting symptom and half of the patients with isolated ON develop MS within 15 years. The diagnosis of ON plays an important role in neurological practice. A correct and early diagnosis is necessary to ensure optimal further investigations and treatment. Other causes of optic neuropathies such as connective tissue disorders, infectious diseases, tumours or ischaemic neuropathies are less frequent but clinical and therapeutic management can differ dramatically. We present five patients admitted to our hospital with suspected demyelinating ON, but the clinical work up revealed different causes of optic neuropathy. We discuss the differential diagnosis of ON and clinical red flags that require careful diagnostic assessment of other diseases. A workflow for the diagnosis of optic neuropathies is presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.